Presentation Information
[EPD1-2]Indications and Outcomes of Conversion Surgery After Immune Checkpoint Inhibitor Therapy for cStage IV and Recurrent Esophageal Cancer
Tomoki Makino, Shigeto Nakai, Kota Momose, Kotaro Yamashita, Koji Tanaka, Hidetoshi Eguchi, Yuichiro Doki (Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka)